
Jai Radhakrishnan, MD, MBBS, MS, FASN, discusses why IgG4-related kidney disease is often missed and what the MITIGATE subgroup data presented at ASN Kidney Week 2026 show.
Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses challenges associated with combining specialty pharmacy operations.
Wright: We are a new company that combines the specialty pharmacies from Prime Therapeutics and Walgreens Specialty Pharmacy. So, our challenges are around how do we bring these 2 strong models together and pick the best of each piece and utilize the best pieces of the platform.
Of course, any specialty pharmacy that were to launch has limited distribution networks to navigate, payer networks to navigate, as well as all of the adherence [challenges]—we are in a highly regulated environment—and to make sure we are actually driving value in that space.




